Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass — Stella

Recruiting

Back to Post-bariatric Surgery trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(2 sites)

United States

Texas Diabetes Institute - University Health System, San Antonio, Texas

South Texas Veterans Health Care System, San Antonio, Texas

Key details

Phase

Very early testing

Sponsor

The University of Texas Health Science Center at San Antonio

Enrollment target

~80 participants

Started

November 2005

Primary completion

August 2026

Age range

18 Years – 65 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov